We describe an assay system for measuring phenobarbital, 
only drugs known to have interfered with the assay are gentamicin, diazoxide, and mephobarbital.
Additional Koyphrases:
reverse-phase chromatography

#{149}
fast, small-sample simultaneous analysis #{149} podia fric chemistry
The ideal procedure for assay of anticonvulsant drugs will be one that provides for the reliable, rapid, economical quantitation, in a micro-scale sample, of all of the commonly used anticonvulsant drugs. The frequency with which new methods for these assays are published indicates the high degree of interest in achieving this goal, but it has not yet been reached. Gas-liquid chromatographic analysis (GLC) of anticonvulsant drugs requires a relatively large sample (frequently as much as 1 ml) and a significant amount of time on sample clean-up and derivatization. In addition, no single set of analytical conditions has as yet been described that is suitable for more than four of the common anticonvulsant drugs. 
Materials and Methods
Apparatus.
Throughout 
Method of Calculation
By taking known amounts of the five drugs and the internal standard through the procedure we demonstrated a linear relationship between peak area and drug concentration over a concentration range far in excess of that required for clinical purposes. In addition, by dividing the peak area for a known amount of each drug by the peak area for an equal amount of the internal standard, we established the relative response factors used in final calculations ( Table 1) .
Precision
We assessed the precision of the method by repeated analyses (procedure 200) of plasma specimens containing therapeutic and toxic concentrations of the drugs being investigated.
As shown in Table 2 , within- The 1LBondapak columns are washed daily with methanol, and weekly with acetonitrile and dimethylsulfoxide. Under the conditions described, a column may be used for about 1200 analyses before requiring replacement.
Results and Discussion
Analytical Variables
Detector wavelength.
Solutions of primidone and ethosuximide absorb
well at 200 nm, but poorly at 254 nm, so that maximum sensitivity for the analysis of these two drugs is provided by the use of a 200-nm detector.
In practice, however, the concentration of ethosuximide is usually high enough to permit its measurement at either 200 nm or 254 nm. Phenobarbital, diphenylhydantoin, and carbamazepine absorb well at both of these wavelengths, so that either detector may be used for their measurement.
Column temperature. With a new column, optimum separation of these drugs was observed at 30 #{176}C ( Figure  1) 
Accuracy
We measured the absolute recovery from plasma of the five drugs and the internal standard in the following way. The six compounds were added to drug-free plasma to achieve the concentrations shown in Table 3 . This plasma was then analyzed by procedure 200, except that the acetonitrile used to precipitate protein did not contain cyheptamide. Carefully measured aliquots of the supernate were then chromatographed and the peak areas determined.
Percentage recovery was calculated by comparing these peak areas with the peak areas obtained by the direct injection of the pure compounds. As shown in Table 3 , absolute analytical recoveries of the drugs ranged from 80% for primidone to 93% for diphenylhydantoin.
The absolute recovery of cyheptamide was 94%. The same experiment with procedure 254 yielded similar results. In Table 2 
